The hard part of genomic research is often getting permission to use what already exists. Lifebit sends the tools to the data, turning institutional boundaries into something a researcher can work across.
The Alphabet spinout tried smart contact lenses, surgical robots and a watch built for research. After layoffs and a strategic reset, its real product looks less cinematic - and potentially more useful: turning health care’s unruly data into evidence, decisions and care.